Powe L - Search Results

1

Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II.

Miller RG, Bouchard JP, Duquette P, Eisen A, Gelinas D, Harati Y, Munsat TL, Powe L, Rothstein J, Salzman P, Sufit RL. Miller RG, et al. Among authors: powe l. Neurology. 1996 Oct;47(4 Suppl 2):S86-90; discussion S90-2. doi: 10.1212/wnl.47.4_suppl_2.86s. Neurology. 1996. PMID: 8858057 Clinical Trial.

2

The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis.

Debove C, Zeisser P, Salzman PM, Powe LK, Truffinet P. Debove C, et al. Among authors: powe lk. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Sep;2(3):153-8. doi: 10.1080/146608201753275508. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001. PMID: 11771772 Clinical Trial.

3

A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.

Lacomblez L, Bensimon G, Leigh PN, Guillet P, Powe L, Durrleman S, Delumeau JC, Meininger V. Lacomblez L, et al. Among authors: powe l. Neurology. 1996 Dec;47(6 Suppl 4):S242-50. doi: 10.1212/wnl.47.6_suppl_4.242s. Neurology. 1996. PMID: 8959996 Clinical Trial.

4

Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis.

Bruno R, Vivier N, Montay G, Le Liboux A, Powe LK, Delumeau JC, Rhodes GR. Bruno R, et al. Among authors: powe lk. Clin Pharmacol Ther. 1997 Nov;62(5):518-26. doi: 10.1016/S0009-9236(97)90047-3. Clin Pharmacol Ther. 1997. PMID: 9390108

5

A pilot study of participatory video in early psychosis: Qualitative findings.

MacDougall AG, Price E, Glen S, Wiener JC, Kukan S, Powe L, Bird R, Lysaker PH, Anderson KK, Norman RMG. MacDougall AG, et al. Among authors: powe l. Qual Res Med Healthc. 2022 Oct 4;6(2):10438. doi: 10.4081/qrmh.2022.10438. eCollection 2022 Oct 4. Qual Res Med Healthc. 2022. PMID: 37440774 Free PMC article.

6

Premier épisode psychotique causé par une encéphalite à anticorps anti–récepteur N-méthyl-d-aspartate.

Marsters C, Iskhakova S, Powe L, Budhram A. Marsters C, et al. Among authors: powe l. CMAJ. 2023 Jun 12;195(23):E823-E826. doi: 10.1503/cmaj.220938-f. CMAJ. 2023. PMID: 37308207 Free PMC article. French. No abstract available.

7

A young adult with first-episode psychosis: when to consider anti-N-methyl-D-aspartate receptor encephalitis.

Marsters C, Iskhakova S, Powe L, Budhram A. Marsters C, et al. Among authors: powe l. CMAJ. 2023 Mar 6;195(9):E330-E332. doi: 10.1503/cmaj.220938. Epub 2023 Mar 5. CMAJ. 2023. PMID: 36878539 Free PMC article. No abstract available.

8

Glutathione as a Molecular Marker of Functional Impairment in Patients with At-Risk Mental State: 7-Tesla ¹H-MRS Study.

Jeon P, Limongi R, Ford SD, Branco C, Mackinley M, Gupta M, Powe L, Théberge J, Palaniyappan L. Jeon P, et al. Among authors: powe l. Brain Sci. 2021 Jul 17;11(7):941. doi: 10.3390/brainsci11070941. Brain Sci. 2021. PMID: 34356175 Free PMC article.

9

Participatory video as a novel recovery-oriented intervention in early psychosis: A pilot study.

MacDougall AG, Kukan S, Price E, Glen S, Bird R, Powe L, Wiener JC, Lysaker PH, Anderson KK, Norman RM. MacDougall AG, et al. Among authors: powe l. Int J Soc Psychiatry. 2020 Dec;66(8):780-784. doi: 10.1177/0020764020932938. Epub 2020 Jun 23. Int J Soc Psychiatry. 2020. PMID: 32571128

10

High-resolution magnetic resonance imaging findings in juvenile-onset myotonic dystrophy.

Peterson AC, Dew MS, Powe LK. Peterson AC, et al. Among authors: powe lk. Arch Neurol. 1989 May;46(5):481-2. doi: 10.1001/archneur.1989.00520410015010. Arch Neurol. 1989. PMID: 2712741 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters